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ABSTRACT 
The Role of Nuclear Factors of Activated T-cells (NFAT) in Neuronal Death 
Agata M. Habas 
November 29, 2004 
Nuclear Factor of Activated T-cells (NFAT) is a calcium-responsive transcription fac-
tor that orchestrates immune response and cardiovascular development. NFAT is 
also present in neurons and glia from the Central Nervous System (CNS) where it 
participates in calcium signaling. In physiological conditions, neuronal NFAT may 
contribute to the plasticity-related transcriptional regulation. On the other hand, 
excessive activation of calcium signaling and the subsequent overactivation of NFAT 
may contribute to neuronal death. To explore the possibility of NFAT-involvement in 
neuronal death I have determined which components of NFAT signaling are expressed 
in cultured rat hippocampal or cortical neurons. I found the presence of mRNAs for 
NFATcl, c3, c4 and c5. I also found that in primary neurons, NFAT transcriptional 
activity is increased by KCI-mediated depolarization or by chemical trophic depri-
vation induced by a PI3K/ Akt signaling inhibitor LY294002. This transcriptional 
activity may be blocked by calcineurin inhibitors: cyclosporin A and FK506 and 
ERKI/2 pathway inhibitor, U0126. Interestingly, overexpression of NFATc4 poten-
tiated apoptotsis induced by trophic deprivation in cortical neurons. In summary, 
these data support the idea that excessive activation of NFAT may produce neuronal 
death following trophic deprivation. In future, I plan to study the mechanism of 
NFAT involvement in neuronal death. 
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The cells of a multicellular organism are members of a highly organized community 
in which the number of cells is regulated by the proliferation or the rate of cell death. 
Mature neurons are non-proliferating cells so their number is regulated mostly by cell 
death. Neurons can undergo cellular suicide by a process known as programmed cell 
death or apoptosis. Cell death plays a very important role during development and 
also in adult organism. Mouse paws for example, are sculpted by cell death during 
embryonic development (Wood et al., 2000; Alberts et al., 2002). When a tadpole 
changes into a frog, the cells in the tail die, and the tail, which is not needed in the 
frog disappears (Wood et al., 2000; Alberts et al., 2002). In the developing nervous 
system, up to half or more of the nerve cells normally die soon after they are formed 
(Wood et al., 2000; Alberts et al., 2002). In this case, cell death adjusts the number of 
nerve cells to match the number of target cells that require innervation (Wood et al., 
2000; Alberts et al., 2002). In adult tissues, cell death balances cell division (Alberts 
et al., 2002). If the physiological cell death is inhibited, cells normally destined to die, 
survive, leading to autoimmune conditions and cancer (Li and Yuan, 1999; Alberts et 
al., 2002). On the other hand, excessive cell death may contribute to several patho-
logical conditions, including stroke and neurodegenerative diseases (Fig. 1) (Putcha 
and Johnson, 2004). Neurons may die in pathological conditions in diseases includ-
ing Parkinson's disease, amyotrophic lateral sclerosis, retinitis pigmentosa, several 
forms of cerebellar degeneration, spinal muscular atrophy, and Alzheimer's disease 
(Hutchins and Barger, 1998; Sastry and Rao, 2000; Yuan et al., 2003). Several fac-
tors, such as oxidative stress, excitatory toxicity, inappropriate Ca2+ homeostasis, 
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mitochondrial dysfunction, and lack of sufficient supply of neurotrophic factors, have 















Figure 1. Regulation of homeostasis. Some diseases characterized by defective cell 
death (left) or excessive cell death (right). 
Neuronal cell death may be divided into at least 2 types: apoptosis and necrosis 
(Petersen et al., 1999; Sastry and Rao, 2000; Habas et al., 2001). Necrosis is a 
passive process, mostly seen in pathologies and is generally pro-inflammatory (Raff 
et al., 1993; Habas et al., 2001; Kanduc et al., 2002). It is characterized by early 
swelling of intracellular organelles followed by swelling and loss of the plasma and 
nuclear membrane integrity (Petersen et al., 1999; Sastry and Rao, 2000). Apoptosis 
is a response to a specific pro-apoptotic signal or weak damage that involves specific 
biochemical events frequently including de novo gene expression in a dying cell (Raff 
et al., 1993; Vaux, 1993; Habas et al., 2001). 
The characteristics of apoptosis include cytoplasmic condensation, nuclear pykno-
sis, chromatin condensation, DNA fragmentation, cell rounding, membrane blebbing, 
cytoskeletal collapse, and formation of membrane bound apoptotic bodies that are 
rapidly phagocytosed and digested by macrophages or neighboring cells (Sastry and 
Rao, 2000; Yuan et al., 2003) (Table 1). Apoptotic neuronal death may play an im-
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port ant role in several pathologies in CNS. Defects in the control of apoptosis leading 
to excessive programmed cell death may contribute to stroke, ischemia, Traumatic 
Brain Injury (TBI), Alzheimer's Disease (AD), Parkinson's Disease (PD), Hunting-
ton's Disease (HD) (Choi, 1996; Ekshyyan and Aw, 2004; Gibson, 2001; Behl, 2000; 
Martin, 2001). 
Apoptosis is a process that requires active cellular events (Pittman et al., 1993; 
Kanduc et al., 2002). Therefore, apoptosis takes longer to kill than the passive 
necrosis and may provide a better therapeutic window to perform neuro-protective 
manipulations (Kanduc et al., 2002). 
Programmed cell death may be inhibited either by activation of anti-apoptotic or 
by inhibition of pro-apoptotic signaling pathway. 
Table 1 Comparative features of necrosis and apoptosis (Sastry and Rao, 2000). 
Necrosis 
Altered membrane permeability; 
Potassium loss; sodium entry; 
fall in membrane potential 
Swelling of all cytoplasmic compart-
ments 
Destruction of mitochondria and other 
organelles 
Depletion of cellular energy (ATP) 
Lowered macromolecular synthesis 
Affects tracts of contiguous cells 
Loose aggregates of chromatin 
Apoptosis 
Cytosol condensation 
Generally intact organelles 
Protruberances from cell surface sepa-
rate to form apoptotic bodies 
No depletion of cellular energy 
Macromolecular synthesis activation is 
required 
Affects scattered individual cells 
Highly condensed granular aggregates 
of chromatin 
There are two major pathways leading to apoptotic death. They both employ act i-
vation of caspases and proteases. The first pathway can be initiated by DNA damage 
or trophic deprivation (TD). The death signal is sent through signaling molecules 
including p53 or JNK to mitochondria from where cytochrome c is released to the 
cytoplasm (Polster et al., 2004; Harada and Grant, 2003). The key regulators of cy-
3 
tochrome c release are proteins from Bcl-2 family including anti-apoptotic members 
like Bcl-2, Bcl-XI, Bag-1 and members that induce apoptosis: Bax, Bad and Bid. 
Cytochrome c leads to formation of an active complex composed of a protein Apaf-1 
and a protease caspase-9. In this complex, caspase-9 becomes active and stimulates 
other caspases including caspase-3, -6 and -7 that execute apoptosis (Fig. 2A) (Green 
and Reed, 1998; Robertson and Orrenius, 2000; Tsujimoto and Shimizu, 2000). 
The second mechanism of programmed cell death includes pro-apoptotic signaling 
molecules known as death receptors such as p75 NGF receptor, TNFR1, Fas/CD95/ 
Apo-1, TRAIL (TNF-related apoptosis inducing ligands), DR4, and DR5 (Krammer, 
2000; Nagane et al., 2000). After binding to their ligands, death receptors activate 
caspase 8 or 10. This is followed by the activation of caspases -3, -6 and -7 (Fig. 2B). 
Therefore, in both apoptotic pathways, programmed cell death occurs via caspase-
mediated cleavage of multiple proteins leading to DNA fragmentation, destruction 
of cellular structures and formation of apoptotic bodies (Thornberry and Lazebnik, 
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APOPTOSIS 
Figure 2. Various pathways of apoptosis. A. Mitochondrial pathway of apoptosis, 
B. Death receptor pathway of apoptosis. 
In summary, programmed cell death is needed for the proper function of each 
organism. Apoptosis is an important factor in various diseases. Both increased or 
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decreased apoptosis may result in pathologies. Therefore, identification of apoptotic 
regulation may provide new opportunities for therapies against such disorders as 
cancer or neurodegeneration. 
Damaging stimuli in the nervous system 
In the nervous system, various damaging stimuli activate signaling pathways that 
trigger cell death including apoptosis. Calcium influx, oxidative stress, DNA damage 
and TD are thought to be important cell death triggers in neurodegenerative diseases, 
traumatic injuries, stroke or ischemia (Simonian and Coyle, 1996; Mason et al., 1999; 
Petersen et al., 1999; Ghatan et al., 2000; Hugon et al., 2000; Lewen et al., 2001; 
Mattson, 2003). 
It is known that intracellular Ca2+ overload can trigger either necrotic or apoptotic 
cell death (Orrenius and Nicotera, 1994; Vajda, 2002). Development of strategies 
that will block apoptotic and non-apoptotic death induced by Ca2+ influx is im-
portant as it may lead to the effective neuroprotection. Several effects of Ca2+ are 
mediated by Ca2+ -binding proteins (e.g. calmodulin or calcineurin) (Orrenius and 
Nicotera, 1994). Cell death caused by calcium overload may be induced by the exces-
sive stimulation of glutamate receptors. Two classes of glutamate receptors have been 
identified: (1) ionotropic glutamate receptors, which are ligand gated ion channels, 
and (2) metabotropic glutamate receptors, which are known as G-protein coupled 
receptors (Uings and Farrow, 2000). Excessive stimulation of the ion channels of 
N-methyl D-aspartate subtype of ionotropic glutamate receptors (NMDA receptors) 
leads to robust increase of Ca2+ load inside the cell and necrotic or apoptotic cell 
death (Orrenius and Nicotera, 1994; Vajda, 2002). On the other hand, moderate 
calcium influx through NMDA receptors plays a key role in neuronal development, 
survival and plasticity (Ghosh and Greenberg, 1995). 
Neurons require the presence of survival factors to suppress cell death. Therefore, 
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TD induces neuronal apoptosis, which in CNS may play a significant role in neu-
rodegenerative diseases, fetal alcohol syndrome and neurotrauma (Hetman and Xia, 
2000; McIntosh et al., 1998; Bhave et al., 1999). It may also playa role in cell death 
during development of the nervous system (Li et al., 2001). A number of survival 
factors for neurons have been identified including serum, insulin like growth factor-1, 
neurotrophins and NMDA. These factors activate the phosphatidylinositol-3 kinase 
(PI3K) pathway, which use one of several signal transduction pathways implicated 
in the survival of neurons (Hetman and Xia, 2000). In primary neuronal culture, 
TD may be induced by serum withdrawal or by inhibition of PI3K pathway using its 
chemical inhibitor, LY294002 (Hetman and Xia, 2000). 
The role of transcription factors in neuronal death 
Apoptotic signaling in neurons leads to activation of killer gene expression that is 
mediated by several transcription factors like p53 or Forkhead box transcription fac-
tor, class 0 (FOXO) (Morrison and Kinoshita, 2000; Brunet et al., 2001). FOXO 
induces death receptors like Fas and FasL, or TRAIL (TNF-related apoptosis induc-
ing ligands), TUmor Necrosis Factor-alpha (TNFa) and its receptor (Brunet et al., 
2001). Another transcription factor HIF (Hypoxia Inducible Factor) and p53, which 
are activated after oxidative stress, promote transactivation of pro-apoptotic bcl-2 
family members leading to neuronal death (Halterman and Federoff, 1999). NFKB 
(Nuclear Factor KB) is a transcription factor, which is activated in response to in-
flammation or oxidative stress. NFKB may serve a dual role in stimulating pathways 
that protect neuronal cells from death by activation of its target genes, Bcl-2 or Bcl-x 
and also in stimulating pathways that promote cell death by induction of TRAIL 
and other death receptors (Tamatani et al., 2000; Wajant, 2004). CCAAT enhancer 
binding proteins (c/EBPs) are transcription factors that playa role in cell survival in 
non-neuronal cells, while in neurons they promote death (Cortes-Canteli et al., 2002; 
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Marshall et al., 2003). Nuclear Factor of Activated T-cells (NFAT) is a transcription 
factor that contributes to lymphocyte death. It does so by regulation of killer genes 
including FasL, Tumor Necrosis Factor-alpha (TNFa), and cyclooxygenase-2 (Cox2) 
in lymphocytes (Lenzlinger et al., 2002; Humar et al., 2004). On the other hand, it 
is known that FasL, TNFa and Cox2 can induce neuronal death and their increased 
expression accompanies ischemia, TBI, stroke and some neurodegenerative diseases 
like AD or PD (Venters et al., 2000; Cernak et al., 2001; Facchinetti et al., 2002; 
Xiang et al., 2002). Therefore, it is possible that activation of NFAT contributes to 
neuronal loss that may play an important role in different neuronal diseases. 
Nuclear Factors of Activated T-cells (NFAT) 
NFAT is a family of transcription factors in which several members are activated in 
response to calcium. The NFAT signaling pathway was first described in lymphocytes 
as a pathway transducing signals from the polymorphic T-cell receptor to genes that 
coordinate an immune response (Graef et al., 2001). Several NFAT members are also 
necessary for the formation of the cardio-vascular system including morphogenesis of 
vertebrate heart valves. On the other hand, their pathological activation may produce 
cardiac hypertrophy (Graef et al., 2001; Crabtree and Olson, 2002). 
Table 2 List of NFAT proteins (Hogan et al., 2003). 
Protein Other names Regulation 
NFATcl NFAT2, NFATc Ca2+ jCalcineurin 
NFATc2 NFAT1, NFATp Ca2+ jCalcineurin 
NFATc3 NFAT4, NFATx Ca2+ jCalcineurin 
NFATc4 NFAT3 Ca2+ jCalcineurin 
NFATc5 TonEBP Osmotic stress 
Integrin (a6(34) activation 
Five NFAT genes NFATc1-4 and NFATc5, have been identified (known also as 
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NFATl-4 and NFAT5; see table 2) (Bushdid et ai., 2003; Hogan et aI., 2003). The 
primordial family member is NFATc5, the only NFAT-related protein represented 
in the Drosophila genome. NFATc5 is identical to TonEBP (tonicity element bind-
ing protein), a transcription factor crucial for cellular responses to hypertonic stress 
(Fig. 3B) (Hogan et aI., 2003). NFATc cytolasmic subunits require other transcrip-
tion factors for DNA binding, including API , MEF2, GATA4 generally referred to 
as nuclear partners (NFATn) (Fig. 3A). The nuclear components of NFAT transcrip-
tion complexes are often regulated by the protein kinase C (PKC) and Ras/MAPK 
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Figure 3. Activation of transcription by NFAT. A. NFATcI-c4 components are 
dephosphorylated and translocated to the nucleus where they bind to the DNA and induce 
several genes like 1L2, 1L3, 1L4, 1L5, 1FNl', TNFa, FasL, CD40L, GM-CSF. To activate 
transcription, they require nuclear partners (NFATn) including API, GATA4 or MEF2. 
B. NFATc5 is activated and localized to the nucleus where it binds to the DNA and induces 
osmotically regulated genes. 
NFATs contain both the nuclear localization sequence (NLS) and the nuclear export 
sequence (NES). (Okamura et aI., 2000; Crabtree and Olson, 2002). Whether NLS 
or NES is masked depends on the phosphorylation state of specific serine residues 
in the regulatory domain (Crabtree and Olson, 2002; Hogan et aI., 2003). Phos-
phorylation of these serine residues exposes NES whereas dephosphorylation exposes 
NLS (Crabtree and Olson, 2002; Hogan et ai., 2003). In resting cells, the NLS of 
the cytoplasmic NFAT is masked due to phosphorylation on these serine residues. In 
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stimulated cells , an increase of intracellular calcium ions activates Ca2+ -dependent 
Ser/ Thr phosphatase, calcineurin (CaN) , which then dephosphorylates the masking 
residues. Consequently, NLS is exposed and NFAT can be carried into the nucleus by 
the importin rx./ (3. Inside the nucleus, NFAT may be re-phosphorylated by protein 
kinases, including Ser/ Thr kinase, Glyconen Synthase Kinase 3(3 (GSK-3(3), Thr/Tyr 
(Threonin/Tyrosin) MAP kinases , p38, cAMP-dependent protein kinase (PKA) and 
Jun N-terminal kinase (JNK), exposing its NES and be exported by the exportin 
(Fig. 4) (Crabtree and Olson, 2002). 
1 Calcineurin 
Figure 4. Regulation of NFAT translocation. NFATcl-c4 components are dephos-
phorylated by calcineurin and translocated to the nucleus by the importin; however, phos-
phorylation of NFAT by kinases activates its translocation to the cytoplasm by the exportin. 
In resting T cells, NFAT is phosphorylated and localized in the cytoplasm. After 
cell stimulation, it is dephosphorylated by CaN and translocated to the nucleus where 
it binds to the DNA (Murphy and Hughes, 2002). It binds to promoter regions and 
induces expression of several genes including cytokines , such as interleukin (IL )2, IL3, 
IL4, IL5 , IL8, 1113, granulocyte-macrophage colony-stimulating factor (GM-CSF) , 
interferon (IFN)-y , and tumor necrosis factor (TNF)a, and cell surface receptors, 
such as CD40L, CTLA-4, and FasL (Masuda et aI. , 1998; Kiani et aI. , 2000; Humar 
et aI. , 2004). NFAT plays a critical role in the coordinate induction of expression of 
these genes (Masuda et aI., 1998) . 
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NFATc5 has distinct characteristics from those of NFATc1-c4. First, the DNA-
binding domain does not bind with Fos or Jun to form NFAT:AP1 heteromeric tran-
scription factor. Second, NFATc5 lacks the conserved regulatory domains of the 
calcium-regulated NFATs and its subcellular distribution is not dependent on cal-
cineurin (Macian et al., 2001). It has been reported that NFATc5 is responsible for 
cellular responses to osmotic stress. In osmotically-stressed cells, NFATc5 expres-
sion is increased and it is localized to the nucleus (Lopez-Rogriguez et al., 1999). 
Moreover, NFATc5 binding elements are present in the regulatory regions of a vari-
ety of osmotically-regulated genes including aldose reductase or sodium-myoinositol 
transporter (Macian et al., 2001). 
NFAT family members were also found in astrocytes and hippocampal neurons 
(Graef et al., 1999; Graef et al., 2001; Jones et al., 2003). The activation of NFAT-
dependent transcription in neurons requires Ca2+ influx via L-type voltage-sensitive 
calcium channel. Neuronal NFAT transcriptional complexes bind to inositol 1, 4, 
5-triphosphate receptor, type 1 (IP3R1) promoter and are likely to be one of the 
transcription factors that regulate activity-dependent expression of this receptor dur-
ing development (Graef et al., 2001). The role of NFAT in the central nervous system 
(CNS) is not well characterized. So far, it was shown that the NFATc4 isoform is in-
volved in neurotrophin-mediated synaptic plasticity and memory formation (Graef et 
al., 1999; Groth and Mermelstein, 2003). Furthermore, it is known that neurotrophins 
and netrins stimulate calcineurin-dependent nuclear localization of NFATc4 and acti-
vation of NFAT-mediated gene transcription in cultured neurons leading to outgrowth 
of embryonic axons. Sensory and commissural neurons lacking calcineurin function or 
NFATc2, c3 and c4 are unable to respond to neurotrophins or netrin-1 with efficient 
axonal outgrowth (Graef et al., 2003). So far, the role of NFAT in neuronal survival is 
not known but it was shown that NFAT is involved in cell survival in cardiomyocytes 
(Pu et al., 2003). NFATc3 and NFATc4 are required for cardiac development and 
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proper mitochondrial function (Bushdid et al., 2003). Moreover, NFAT transcription 
factors are involved in hypertrophy, but they are also critical survival factors that in-
hibit cardiomyocyte apoptosis induced by calcineurin activation (Pu et al., 2003). It 
has been also shown that NFATc1 and NFATc2 are involved in cell death in lympho-
cytes (Humar et al., 2004; Cernal et al., 2001; Venters et al., 2000a; 2000b; Xiang et 
al., 2002). Moreover, NFAT is involved in activation of various killer genes including 
FasL, TNFa. and Cox2, which cause death in neurons. Therefore, I decided to check 
whether NFAT is involved in neuronal apoptosis. 
Possible involvement of NFAT in neuropathologies 
Graef and co-workers reported that NFAT activity is present in neurons and is induced 
by calcium (Graef et al., 1999). So far, it was shown that NFAT is an important me-
diator of T-cell apoptosis (Linette et al., 1996; Srivastava et al., 1999). Moreover, Dr. 
Michal Hetman found that cortical neurons overexpressing NFATc4 undergo apop-
tosis (Fig. 5) while cells receiving a dominant negative mutant form of NFATc4 are 
partially protected from cell death induced by TD (Fig. 6) (unpublished observation). 
Consequently, I hypothesize that excessive NFAT activation may playa crucial role 
in neuronal death in neurological diseases. 
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Figure 5. Overexpression of NFATc4 induces neuronal apoptosis. (A) Neurons 
were transfected for 48 hours with pBJ-NFATc4 wt and the f3-galactosidase expression 
plasmid pON260 (0.6 ~g + 0.2 ~g of plasmid DNA/well). Expression of recombinant 
proteins was studied by immunostaining (green - HA epitope tag of NFATc4, red - 13-
galactosidase). Morphology in transfected cells was verified by staining with Hoechst 33258. 
Transfected cells were identified by immunostaining for f3-gal and Hoechst staining identified 
whether the cell was dead or alive. (B) NFAT-mediated transcription was assayed 48 hours 
after transfection of NFAT-Luc reporter (0.12 ~g/well) + pBJ5 empty cloning vector or wt 
NFATc4 or a dominant negative NFATc4 mutant, e-delta (0.48 ~g/well). EFILacZ was 
added to normalize for transfection efficiency. (e) Neurons were transfected using calcium 
phosphate method with pBJ5 empty cloning vector, pBJ5-NFATc4 wt or pBJ5-NFATc4e-
delta and co-transfected with f3-galactosidase expression plasmid, pON260 (0.4 ~g NFATc4 
+ 2 ~g pON260 of plasmid DNA/2 millions cells in a 35 mm dish). Neuronal apoptosis in 
transfected cells were identified by immunostaining for f3-gal and by Hoechst 33258 staining. 
In (B) and (e) n = 3 in triplicate determinations, the error bars are SEMs. 
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Figure 6. Inhibition of NFATc-driven transcription by NFATc4-delta reduces 
neuronal apoptosis induced by trophic deprivation. Neurons were transfected with 
NFAT-Luc reporter (0.12 gjwell) + pBJ5 empty cloning vector or a dominant negative 
pBJ5-NFATc4 mutant, C-delta (0.48 gjwell). EF1LacZ was added to normalize for trans-
fection efficiency. Twenty four hour-apoptotic treatments were initiated 48 hours after 
transfection. LY, LY294002 (30 ~M), O%B, medium without serum. Results for n = 2 
(duplicate determinations in 1 representative experiment), the error bars are BEMs. 
To set the stage for further testing of this possibility, I studied expression of var-
ious NFATc family members in rat primary cortical and hippocampal neurons and 





Dominant-negative mutant of NFATc4 was generated by Dr. Hetman through dele-
tion of the C-terminal DNA binding domain starting at amino acid 439 of human 
cDNA for NFATc4. The mutant was then cloned N-terminally to the HA tag in pBJ5 
mammalian expression vector. Expression plasmid for wt and constitutive active 
NFATc4 are described (Graef et al., 1999; Neal and Clipstone, 2003; Schubert et al., 
2003). Expression plasmid for wt NFATc1 is described (Beals et al., 1997). 
Drugs 
Pharmacological agents that were used are commercially available and were dissolved 
using appropriate solvents. KCl (30 mM; VWR) was dissolved in H20; LY294002 
(30 ~M; Sigma) was dissolved in DMSO; CsA (1 ~g/ml; Bedford Laboratories) was 
dissolved in 0.9% sodium chloride; FK506 (200 ng/ml; A.G. Scientific, Inc.) was 
dissolved in DMSO; U0126 (40 ~M; Sigma) was dissolved in DMSO. 
Antibodies 
Anti-l3gal (1:500, rabbit; Calbiochem) and anti-HA (1:80, mouse; Novus biologicals) 
were used for immunostaining as primary antibodies. Texas Red-conjugated goat an-
tibody to rabbit IgG (1:100; Calbiochem) or for double staining additional secondary 
antibody FITC-conjugated goat antibody to mouse IgG (1:100; Calbiochem), was 
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used for immunostaining as secondary antibodies. 
Cell culture 
Primary culture of cortical and hippocampal neurons were prepared from newborn 
Sprague-Dawley rats according to the established protocols (Furshpan and Potter, 
1989; Bading and Greenberg, 1991). Culture medium was Basal Medium Eagel 
(BME) supplemented with 10% heat-inactivated bovine calf serum (Hyclone, Logan, 
Ut), 35mM glucose, 1mM L-glutamine, 100 U /ml of penicillin, 0.1 mg/ml strepto-
mycin. Cytosine arabinoside (AraC) (2.5 JlM) was added to cultures on the second 
day after seeding (DIV 2) to inhibit the proliferation of non-neuronal cells. AraC at 
this concentration does not affect neuronal survival (Hetman et al., 1999). Cortical 
neurons were seeded in concentration of 2 million cells/35 mm plate or 0.5 million 
cells/well on 24-well plate. Hippocampal neurons were seeded in concentration of 
0.6 million of cells/35 mm plate or 0.15 million of cells/well on 24-well plate. Us-
ing this procedure, the cultures consist of about 80-90% MAP-2 positive neurons 
and about 10% of GFAP positive astrocytic cells at DIV5 (Hetman et al., 1999a). 
All experiments were performed at in vitro days 6 or 7, when the newborn-derived 
neurons are susceptible to oxidative stress, excitotoxicity, DNA damage agents or TD 
(Hetman et al., 1999; Hetman et al., 2002). Both cortex and hippocampus ensure 
enough cells to perform biochemical analysis such as promoter assays, western blots 
or electromobility shift assays. 
RT -PCR assay 
RNA for RT-PCR was isolated from neurons using the SV Total RNA Isolation 
Kit (Promega). cDNA synthesis was done using a AMV cDNA synthesis kit from In-
vitrogen. Primers, designed using OligoExplorer freeware from University of Koupio, 
15 
as follows: 
NFATcl sense-aacgccctgaccaccgatag, asense-gctgccttccgtctcatagtg; 
NFATc2 sense-ctgccagcttcatttctgacacct, asense-ttgagggcatccatgagaacagca; 
NFATc3 sense-gtagagactgacatccctttg, asense-atctgtagatttattggcttttc; 
NFATc4 sense-tgccaacattgactgtgctgga; asense-acaccactttagagtctggcagga; 
NFATc5 sense-gccaaagcacctcactatg, asense-gcagggagttgtatttcg. 
PCR was run using standard protocols and MJ Research thermal cycler. Reaction 
product was analyzed by agarose gel electrophoresis. 
Transfection of neurons 
Neurons were transfected using Lipofectamine 2000 reagent (Invitrogen) at DIV3-4 
according to the established protocols (Hetman et al., 2002). Medium from 24-wells 
plates was collected and replaced by transfection media - Basal Medium Eagel (BME, 
BioWhittaker) supplemented with 35mM Glucose, 1mM L-glutamine, 100 V/ml of 
peniciline and 0.1 mg/ml streptomycine. 'fransfection mixture contained 100 ~ per 
well of BME, 0.6 J.!g per well DNA and 1.5 J.!llipofectamine 2000 per well (Invitrogen). 
First, 50 J.!l of BME was mixed with lipofectamine in one eppendorf, another 50 ~ 
of BME was mixed with DNA in another eppendorf and then the two mixtures were 
mixed together and incubated 20-60 minutes in room temperature before adding to 
the cells. Cells were transfected with 100 ~ of transfection mixture per well and were 
incubated 2 hours at 37°C under a water saturated atmosphere of 95% ambient air 
and 6.5% CO2 . 'fransfection medium was then removed and replaced by conditioned 
medium collected from the cells 2 hours earlier that was supplemented with 19/ml 
glucose and centrifuged in 1000 rpm by 10 minutes in room temperature in order to 
get rid of dead cells. Cells transfected with plasmid conjugated with EGFP could be 
seen live or after fixation without immunostaining. 
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Immunostaining 
Cortical neurons plated on 24-wells plates were co-transfected using Lipofectamine 
2000 (Invitrogen) with NFATc4 wt, with NFATc4 tagged with hemaglutinin (HA) 
or Sf(X together with pON260. Two days after transfection, cells were treated with 
drugs (LY294002, 30 J.lM or serum deprivation) then fixed or untreated cells were fixed 
with 4% para-formaldechyde in PBS. After washing with PBST (phosphate buffered 
saline - PBS, Triton 0.1 %), cells were permeabilized with 0.5% NP40 diluted in PBS 
for 30 minutes, then all unspecific sites were blocked with 2.5% BSA, 2.5% horse 
serum diluted in PBST overnight. Next, primary antibody, that was either anti-j3gal 
(1:500, rabbit) or anti-gal (1:500, rabbit) mixed with anti-HA (1:80, mouse), was 
added to the cells and was incubated for 2 hours in room temperature. Then, cells 
were washed 3 times with PBST and secondary antibody was added that was Texas 
Red-conjugated goat antibody to rabbit IgG (1:100) or for double staining additional 
secondary antibody FITC-conjugated goat antibody to mouse IgG (1:100) was used 
and cells were incubated with these antibodies 1 hour in room temperature. Then, 
cells were washed with PBST and additionally stained with Hoechst 33258 to visualize 
the nuclei. 
Reporter assay 
Cortical neurons plated on 24-well plates were transfected using Lipofectamine 2000 
(Invitrogen) with 0.2 J.lg/well NFATc-Luc (Graef et al., 1999) and 0.125 J.lg/well 
EF1cx.LacZ DNA for normalization of transfection efficiency. Two days after trans-
fection, cells were treated with 30mM KCI and incubated for 24 hours. Then, cells 
were lysed with 100 J.lI/well of reporter lysis buffer (Promega) and activities of lu-
ciferase or j3-galactosidase were measured as described using Orion II Luminometer 
and Promega reagents (j3-galactosidase Enzyme Assay System with Reporter Lysis 
Buffer and Luciferase Assay System). The reporter gene luciferase activity was nor-
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malized to j3-galactosidase activity expressed as the fold induction relative to the 
control. 
Serum deprivation 
Serum deprivation was performed as described previously (Hetman et al., 1999). 
Briefly, cells were washed twice with serum-free BME and incubated in serum-free 
BME supplemented with 35 mM glucose, 1 mM L-glutamine, 100 U /ml penicillin, 
0.1 mg/ml streptomycin, and 2.5 mM cytosine arabinoside (all from Sigma). Control 
cells were washed similarly and then incubated for matched time points in serum-




To identify which members of NFAT family are present in neurons, I performed RT-
PCR assay using NFAT-specific primers and cDNA from primary cortical or hip-
pocampal neurons or from PI brain. As a positive control, I used cDNA from new-
born rat tissues including heart , spleen and thymus. It is known that in these tissues 
several NFATc family members are expressed. My results indicate that NFATc1, 
NFATc3, NFATc4 and NFATc5 are present in mRNAs isolated from cultured cortical 
















Figure 7. Expression of NFAT family members in cultured neurons. Half j.1g of 
DNAs and 2 J.1M specific primers were used for each peR reaction. For NFATcl the number 
of cycles was 29, for NFATc2, NFATc3, NFATc4 and NFATc5 - 32 cy"cles. Equal amounts 
of template were further confirmed by peR with GAPDH-specific primers. Tissues were 
isolated from newborn rats, neuronal cDNA was prepared from cells 6 days after plating 
(DIV6). peR products were analyzed by agarose electrophoresis. 
Then, I tested whether NFAT-mediated transcriptional activity is present in pri-
mary cortical neurons. I transfected cortical neurons with a plasmid construct that 
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contains a luciferase reporter gene under control of an NFAT promoter. Three days 
after transfection , I stimulated cells for 20 hours with 30mM KC!. Luciferase activity 
in neurons transfected with the reporter was 2000 times higher than in untransfected 
cells. Interestingly, NFAT-mediated transcription was further stimulated with KCl 
exceeding the control values by 2.5 times. It suggests that NFAT activity is present 
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Figure 8_ Calcineurin and MAPK pathways dependent activation of NFAT-
mediated transcription in cortical neurons by KC!. (A) Cells were transfected with 
NFAT-Luc reporter (0.2 ~g plasmid DNA/well in a 24-well plate) and EFllacZ plasmid 
(0.125 ~g plasmid DNA/well). Three days after transfection, cells were treated with 30 mM 
KCl for 24h. Neurons were lysed and luciferase activity was measured. (B), (C) Cells were 
transfected in (C) with pBJ5-NFATcl wt (0.1 ~g plasmid DNA/well) or in (B) with pBJ5-
NFATc4 wt (0.1 ~g plasmid DNA/well) and with NFAT-Luc (0.2 ~g plasmid DNA/well) 
reporter and EFllacZ (0.125 ~g plasmid DNA/well) plasmid to normalize for transfection 
efficiency. After 72h cells were pretreated with cyc1osporin A, CsA (1 ~g/ml) and FK506, 
FK (0.2 ~g/ml) or with U0126 (40 ~M) for 30 min. and then were treated with 25 mM KC!. 
After another 20h, cells were lysed and luciferase activity was determined. In (A) n = 3 
(triplicate determinations in 1 representative experiment), in (B) and (C) n = 6 (triplicate 
determinations from 2 representative experiments), the error bars are SEMs. 
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Next, I overexpressed pBJ5-NFATc4 wt or pBJ5-NFATcl wt isoforms in cortical 
neurons. The transfection efficiency using Lipofectamine ranged from 0.1 to 10% 
of neurons. Three days after transfection, I stimulated cells with 25 mM KCI in the 
presence or absence of calcineurin's inhibitors: Cyclosporin A (CsA) and FK506 (FK) 
or MAPK pathway blocker, U0126. I noticed that after overexpression of NFATc4 
wt, NFAT-mediated transcription was increased above 150 times by KCI. Similarly, 
after overexpression of NFATcl wt, KCI induced NFAT-mediated transcription, which 
was increased above 40 times. Interestingly, this phenomenon was blocked in both 
cases by calcineurin inhibitors and by MAPK pathway inhibitor (Fig. 8B and 8C). 
These data suggest that in cortical neurons, both calcineurin and MAPK pathways 
are involved in KCI response activating NFAT-mediated transcription. 
It is known that in non-neuronal cells, activation of NFAT is regulated by Ca2+ 
influx leading to translocation of NFAT from the cytoplasm to the nucleus where 
it activates gene transcription. To test this phenomenonon, I transfected cells with 
pNFATc4 EGFP fusion protein and stimulated cells with 25 mM KCI two days after 
transfection. My data indicate that in the absence of KCI, NFATc was present in 
pericarial cytosol and in the processes. In the presence of KCI, NFATc was translo-
cated to the nucleus (Fig. 9). These data show that NFAT can be translocated to 
the nucleus upon Ca2+ influx. 
25 mM KCI 
control 4 hours 8 hours 
Figure 9. Translocation of NFATc. Cortical neurons were transfected with pNFATc4-
EGFP and 48 hours later were treated with 25 mM KC!. Green staining indicates localiza-
tion ofNFATc4-EGFP fusion protein that is translocated to the nucleus after KC) treatment. 
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To check if proapoptotic stimulation with LY294002, which is a chemical inhibitor of 
the main trophic support signaling pathway, phospatidylinositol-3-kinase (PI3K) can 
increase NFAT driven transcription, cortical neurons were co-transfected with NFAT-
Luc reporter, pBJ5NFATc4 wt and EFllacZ. Three days after transfection, cells were 
treated with LY294002 in the presence or absence of calcineurin's inhibitors, CsA 
and FK or MAPK pathway blocker, U0126. Cells treated with vehicle were used as a 
control. LY294002 induced almost lO-fold increase in NFAT-mediated transcription, 
which was blocked by CsA + FK and by U0126 (Fig. 10). These results suggest that 
NFATc4-mediated transcription is activated by the inhibitor of PI3K via calcineurin 
and MAPK pathways. 
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Figure 10. Activation of NFATc4-mediated transcription by LY via calcineurin 
and MAPK pathways. Cells were transfected with pBJ5-NFATc4 wt (0.1 mg plas-
mid DNA/well) and with NFAT-Luc (0.2 mg plasmid DNA/well) reporter and EF1lacZ 
(0.125 mg plasmid DNA/well) plasmid to normalize for transfection efficiency. After 72h, 
cells were pretreated with cyclosporin A, CsA (1 mg/ml) and FK506, FK (0.2 mg/ml) or 
with U0126 (40 mM) for 30 min. and then were treated with inhibitor of PI3K, LY294002 
(30 mM). After 20h, cells were lysed and luciferase activity was determined. Results for 
n = 3 (triplicate determinations in 1 representative experiment), the error bars are SEMs. 
In order to test a possible NFAT involvement in apoptosis, I co-transfected cortical 
neurons with NFATc4 wt or empty vector (srex) in the presence of f3-galactosidase ex-
pression plasmid that was a marker for the transfection. Two days after transfection, 
apoptosis was induced by serum deprivation and LY294002 treatment. After 24 hours 
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of incubation, cells were fixed and immunostaining were performed. The number of 
transfected apoptotic cells was scored (Fig. 11). Expression of NFATc4 wt was visi-
ble in cortical neurons after immunostaining. Data show that expression of NFATc4 
wt was sufficient to enhance neuronal death induced by both serum deprivation and 
LY294002 treatment from 20-25 to 40%. 
A. B. 
.VEH 
50 • LY 







0 Ci' 10 
0 
sra NFATc4wt 
Figure 11. NFATc4 wt magnifies cell death in cortical neurons after trophic 
deprivation. (A) Neurons were transfected for 48 hours with pBJ-NFATc4 wt and the 
f3-galactosidase expression plasmid, pON260 (0.6 jlg + 0.2 jlg of plasmid DNA/well). Ex-
pression of recombinant proteins was studied by immunostaining (green - HA epitope tag 
of NFATc4, red - f3-galactosidase). Morphology in transfected cells was verified by staining 
with Hoechst 33258. Transfected cells were identified by immunostaining for f3-gal and 
Hoechst staining identified whether the cell was dead or alive. (B) Cortical neurons were 
transfected with empty vector, Sm (0.4 jlg of DNA/well) , pBJ-NFATc4 dominant neg-
ative mutant or pBJ-NFATc4 wt (0.2 jlg of plasmid DNA/well) and the f3-galactosidase 
expression plasmid, pON260 (0.2 jlg DNA/well). Two days after transfection, cells were 
treated with serum deprivation or LY294002. The effectiveness of transfection was studied 
by immunostaining with f3-galactosidase. The morphology of transfected cells was verified 
by staining with Hoechst 33258. The number of dead cells as counted using a microscope. 
Results for n = 3 (triplicate determinations in 1 representative experiment) , the error bars 
are SEMs. 
In summary, my data suggest that NFAT is present in primary neuronal cultures. 
Moreover, its transcriptional activity is induced by calcium influx or TD. In both 
cases, calcineurin and MAPK pathways are required for the activation. Furthermore, 




I found that several members of the NFATc family are expressed in postnatal hip-
pocampal and cortical neuronal cultures. Furthermore, I demonstrated that NFAT 
could mediate transcription response in these cells following KCI stimulation. I also 
found that, in KCI treated cells, calcineurin and MAPK pathways were required for 
NFAT-driven transcription and that it was accompanied by NFATc translocation 
to the nucleus. Interestingly, I observed activation of NFAT-mediated transcription 
following LY294002 treatment. This activation may involve calcineurin and MAPK 
pathways. In addition, L Y294002 treatment or TD induced more apoptosis in cortical 
neurons that overexpressed NFATc4 wt. Therefore, I propose that in neurons, NFAT 
may be involved in TD-induced apoptosis. 
Using RT-PCR, the expression of NFATc1, NFATc3, NFATc4 and NFATc5 was 
found in primary cortical and hippocampal neurons. So far, NFATc expression was 
shown in non-neuronal cells including lymphocytes, natural killer cells and astrocytes 
(Lyakh et al., 1997; Viola et al., 1998; Jones et al., 2003). In hippocamal neurons, 
expression of only one NFATc isoform, NFATc4, has been reported (Graef et al., 
1999). My data suggest that it is also present in cortical neurons. Expression of other 
NFATc isoforms including NFATc1, NFATc3 and NFATc5 in neurons is described 
for the first time in this thesis. Cortical and hippocampal neurons are not pure 
neuronal cultures. These cultures may also contain astrocytes. The culture protocol 
procedure that was used in this research was reported to result in primary cortical 
cultures consisting of 90% of neurons and 10% astrocytes (Hetman et al., 1999). 
Therefore, immunocytochemistry or in situ hybridization is needed to confirm that 
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NFATc1, c3, c4 and c5 are indeed expressed in neurons. NFATc2, which was not 
expressed in neurons, may play an important role in other cell types. For example, 
in lymphocytes, its expression leads to cell death (Peng et al., 2001). However, lack 
of NFATc2 expression in neurons suggests that other NFATc isoforms are responsible 
for the role that NFATc2 plays in other cell types. It suggests that NFATc isoforms 
may activate different genes in various cell types. 
Importantly, the various isoforms of NFAT family may mediate diverse responses 
in the CNS as NFATc1 and NFATc3 are regulated by Ca2+ /calcineurin pathway 
while NFATc5 is regulated by osmotic stress (Hogan et al., 2003). My data indicate 
that non-toxic, membrane depolarizing concentration of KCI activated endogenous 
NFAT in cortical neurons. Moreover, NFAT-mediated transcriptional activity was 
induced by KCI in cells overexpressing NFATc1 wt and NFATc4 wt. Inhibition of 
calcineurin or MAPK pathways blocked the induction. Similarly, NFAT activation 
by KCI that required calcineurin has been shown previously in hippocampal neurons 
and that K+ depolarization acts specifically through L-type Ca2+ channels (Graef et 
al., 1999). My data show that KCI induced NFAT-dependent transcription was not 
blocked by inhibition of NMDA receptors, which are another major Ca2+ channel 
in neurons (data not shown). Therefore, in cortical neurons, activation of NFAT-
mediated transcription by calcium influx is likely mediated by L-type Ca2+ channels. 
It is known that Ras/MAPK pathway is activated after membrane depolarization, 
which leads to calcium influx through L-type Ca2+ channels in PC12 cell lines, in 
cortical primary cultured neurons and in cerebellar granule neurons (Bading and 
Greenberg, 1991; Rosen et al., 1994; Borodinsky and Fiszman, 1998). My data show 
inhibition of NFAT-mediated transcription activity after blocking the ERK1/2 path-
way. Therefore, it suggests that ERK1/2 participates in NFAT activation by calcium 
influx. In many cell types including lymphocytes or cardiomyocytes, Ras/MAP ki-
nase signals facilitate NFAT-dependent transcription (Crabtree and Olson, 2002). 
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My results provide the first report suggesting ERK involvement in NFAT activation 
in neurons. It suggests that neuronal signaling machinery, which regulates NFAT, is 
similar to that of lymphocytes and cardiomyocytes, which required both calcineurin 
and ERK to activate NFAT (Genot et al., 1996). 
My data indicate that in cortical neurons NFATc4-mediated transcription is in-
duced by LY294002 treatment. Interestingly, the NFATc4-driven transcription acti-
vation triggered by L Y294002 required calcineurin and MAPK pathways. It is known 
that in primary neurons L Y294002 blocks the main trophic support signaling path-
way by inhibition of PI3K, which in consequence activates GSK3(3 (Hetman et al., 
2000). This activation may inhibit NFATc (Graef et al., 1999). At the moment, it is 
unclear how NFATc escapes this inhibition in LY-treated neurons. Some possibilities 
may include: (i) activation of stress-activated JNK pathway by TD (Xia et al., 1995), 
or (ii) activation of TNFa,R by inhibition of PI3K that leads to calcium influx and 
therefore, calcineurin activation (Wang et al., 2002). It is known that JNK pathway is 
activated by TD (Xia et al., 1995; Le-Niculescu et al., 1999), which modulates activity 
of AP-1, leading to induction of FasL and cell death in neurons (Le-Niculescu et al., 
1999; Raoul et al., 1999). Activation of AP1 by JNK may counteract the inhibitory 
regulation of NFAT by GSK3(3 resulting in activation of NFAT-driven transcription. 
Another possibility is that TD triggers calcineurin activation that can antagonize 
increased NFATc phosphorylation by GSK3(3. Indeed, calcium signaling may be ac-
tivated by stimuli active during TD. For instance, in colon cancer cells, TNF<x, which 
is also a NFAT target gene, activated TNF<xR leading to calcium influx (Wang et al., 
2002). 
The role of NFAT activation by TD or by LY294002 treatment in neurons is un-
clear. An interesting possibility is that NFAT is involved in TD-triggered cell death. 
Interestingly, NFAT was shown to playa role in cell death of lymphocytes (Srivastava 
et al., 1999; Youn et al., 2000). The unpublished data from Dr. Hetman's laboratory 
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suggests involvement of NFATc4 in neuronal death (see Fig. 5 in the introduction). 
For instance, overexpression of NFATc4 wt increased number of apoptotic cells, while 
inhibition of NFAT by a dominant negative mutant, had no effect on cell death. This 
result suggests that the active NFATc4 isoform may be a pro-death factor in neurons. 
Moreover, I found enhancement of cell death in neurons overexpressing NFATc4 after 
TD. This observation indicates that NFATc4 may be a stress-activated transcription 
factor, which together with other transcription factors including FOXO, mediates 
cell death in neurons. NFATc4 may bind to DNA and NFATn components forming 
a complex like they do in non-neuronal cells to subsequently activate NFAT target 
genes including killer genes like FasL, Cox2 or TNFcx that were implicated in neuronal 
death (Venters et al., 2000a, b; Cernak et al., 2001; Facchinetti et al., 2002; Xiang et 
al., 2002). 
Other transcription factors were also shown to trigger various cellular responses 
depending on the activating stimulus. In neurons, contribution of NFKB to pro- and 
anti-apoptotic events has been reported. For instance, TNFcx is able to protect pri-
mary hippocampal neurons exposed to excitotoxic and apoptotic insults (Cheng et 
al., 1994; Barger et al., 1995) via NFKB-mediated expression of several anti-apoptotic 
genes including an antioxidant defense enzyme, manganese superoxide dismutase 
(MnSOD), and cell death inhibitors Bcl-2, Bcl-xL and lAPs (Dixon et al., 1997; 
Mattson et al., 2000). Pro-apoptotic role of NF KB has been shown by activation of 
NMDA receptor by the excitotoxin quinolic acid, which triggers NFKB activation and 
increase of pro-apoptotic effectors of NFKB activity: p53 and c-myc expression (Qin 
et al., 1999). NFKB-dependent activation of other killer genes including CD95 was 
shown during neuronal death caused by ischemia (Schneider et al., 1999). 
Other transcription factors also act in similar ways leading either to cell death 
or survival. AP1 is an example of a transciption factor whose induction results in 
activation of various genes, such as apoptosis enhancers, FasL or Bim, or apoptosis 
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inhibitors including Bcl3 (Shaulian and Karin, 2002). The regulation and function 
of transcription factors playing dual roles are highly complex. These transcriptions 
factors are also important regulators of many aspects of the cellular response. Their 
differential activation can result in the regulation of different target genes through 
differences in the DNA-binding affinity. Interactions with various DNA-binding pro-
teins, often resulting in cooperative DNA-binding, can determine which genes become 
activated by transcription factors. Moreover, coactivator and co-repressor complexes 
are often required for the transcription factors function. Therefore, transcription fac-
tors working together and operating as a part of a network of coordinately regulated 
DNA-binding proteins determine the gene expression required for the response to a 










Figure 12. Activation of NFAT in cortical neurons. NFAT is activated by KCI or 
TD via calcineurin and MAPK pathways leading to NFAT nuclear translocation where it 
binds to DNA and its nuclear partners, NFATn incluing AP1, GATA4 or MEF2. Formation 
of such complex induces activation of transcription. 
Similarly, NFAT can play differential roles in neurons. Depending on pro-survival 
or pro-death stimuli that activated NFAT, it may transactivate distinct sets of genes 
producing either cell survival or death. It is the balance between pro-apoptotic and 
anti-apoptotic target genes that will determine whether the final outcome will be cell 
survival or cell death and that balance may be set at different points for various cell 
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types (Shaulian and Karin, 2002). Also, different isoforms of NFAT may be selectively 
activated by different stimuli to regulate either survival or killer genes. For instance, in 
lymphocytes, activation of NFATc1 and NFATc2 isoforms leads to cell death (Peng et 
aI., 2001) while activation of NFATc3 plays a pro-survival role (Oukka et aI., 1998). 
Therefore, in neurons, various isoforms of NFAT can have opposite effects on cell 
survival. 
In the work presented here I report that NFAT is expressed in cortical and hip-
pocampal neurons. Furthermore, I found activation of NFAT-mediated transcription 
by pro-survival KCI and pro-apoptotic LY294002 treatment. Both stimuli activated 
NFAT via calcineurin and MAPK pathways. Apoptosis induced by serum depriva-
tion and LY294002 treatment was increased in NFATc4 wt overexpressing neurons 
suggesting that NFAT may regulate killer genes (Fig. 12). Therefore, these results 
indicate the importance of NFAT as a transcription factor playing a role in the reg-
ulation of a balance between pro-apoptotic and anti-apoptotic target genes. Further 
studies are needed to identify the role of NFAT signaling in trophic deprived or trophic 
supported neurons. 
Future directions 
It is known that when NFATc is activated, it is translocated to the nucleus where 
it binds to its nuclear partners and to DNA (Crabtree and Olson, 2002; Neal and 
Clipstone, 2001). Therefore, I plan to use Electromobility Shift Assay (EMSA) to 
study DNA binding activity to NFAT-response elements in nuclear proteins isolated 
from cortical and hippocampal neurons treated with LY294002, serum withdrawal or 
KCI (Lyakh et aI., 1997). Lysates will be collected at different times after treatment. 
To identify DNA binding components of NFAT, an Electromobility Supershift Assay 
(ESA) with specific antibodies against NFAT nuclear partners including API, GATA4 
and MEF2 will be used. Similarly, antibodies against NFATc family members will 
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be used to identify which members are involved in NFAT-mediated transcription. An 
alternative approach for these methods might be Chromatin Immunoprecipitation 
assay (ChIP), which can use antibodies to precipitate DNA bound by transcription 
factors. Moreover, in contradistinction to EMSA, it can be used in vivo, providing 
a powerful tool to unravel the basic mechanism in gene expression. 
Data obtained in our laboratory show that NFATc4 mediates apoptosis in cortical 
neurons. Therefore, I will study neuroprotective effect after NFAT blocking. I showed 
that NFAT activation is calcineurin and MAPK pathways-mediated, so I will identify 
whether calcineurin inhibitors, cyclosporin A and FK506 or MAPK blocker, U0126 
protect against TD or LY294002-induced neuronal apoptosis mediated by NFATc4. 
Because cyclosporin A additionally inhibits the mitochondrial permeability transi-
tion pore and is neuroprotective (Scheff and Sullivan, 1999; Santos and Schauwecker, 
2003), first I will investigate whether FK506 blocks NFAT activation and translo-
cation alone. Subsequently, I will test whether FK506 blocks neuronal apoptosis. 
Next, I will verify if NFAT-induced neuronal apoptosis is isoform-specific. I will 
achieve that by overexpressing neurons with other NFAT wt isoforms in the pres-
ence of j3-galactosidase expression plasmid, which will be exposed to TD. I will use 
pBJ5-NFATc4 delta mutant as an NFAT blocker, because it blocks all other NFAT 
isoforms. I will use empty vector pBJ5 as a control. After various time points, I will 
fix cells, then do immunostaining and verify apoptosis in correlation to transfected 
cells. In addition, lentiviral vectors will be used to transduce neurons with NFAT 
wt, ca, dominant negative forms or VIVIT (Naldini et al., 1996). Dominantnegative 
mutants of NFATc4 inhibit all members of the NFATc family (NFATcl-4). It is gen-
erated by deletion of the C-terminal DNA binding domain and blocks the binding of 
NFAT to DNA (Chow et al., 1999). VIVIT blocks NFATcl-4 interactions with the 
phosphatase, calcineurin, which mediates NFATc activation through Ca2+ influx. It 
is a high-affinity calcineurin-docking peptide, which was selected from combinatorial 
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peptide libraries based on the calcineurin-docking motif of NFAT (Aramburu et al., 
1999). Lentiviral vectors transduction gives high efficiencies (90%), so MTT assays 
will be used for verification of neuronal survival. 
I hypothesize that NFAT activation, which is calcineurin and MAPK-mediated can 
be opposed by p38 or PKA kinases. I plan to test regulation of NFAT by p38 and 
PKA using MKK3 and/or MKK6 ca mutants to activate p38, forskolin and Sp-cAMP 
to activate PKA. These tools will be used to test whether activation of p38 and PKA 
can decrease NFAT-driven transcription in neurons. To assess the possible involve-
ment of p38 or PKA in regulating NFAT-induced apoptosis, I will express NFATc wt 
and treat cortical or hippocampal neurons with p38 or PKA activators. SB202190 or 
SB 203580 (p38 inhibitors) and H89 or Rp-cAMP (inhibitors of PKA) will be used 
to study the contribution of p38 and PKA to NFAT-mediated apoptosis that will be 
assessed by immuno- and bisbenzimidine staining. If p38 and PKA are involved in 
regulation of NFATc, their activation should block NFAT nuclear translocation and 
inhibit neuronal apoptosis. Inhibition of these kinases should abolish the protective 
effect of p38 or PKA activators. Activation of NFAT leads to transcriptional activaton 
of various genes including FasL, TNFa and Cox2, which are implicated in neuronal 
death (Humar et al., 2004; Cernak et al., 2001; Venters et al., 2000a; 2000b; Xiang 
et al., 2002). Therefore, I plan to evaluate possible involvement of FasL, Cox2 and 
TNFcx in NFAT-induced neuronal death. In order to study expression of these fac-
tors, protein lysates will be collected from neurons treated with L Y294002 or trophic 
withdrawal and westerns will be performed. If expression of these proteins increases 
after NFAT activation, TNFcx and FasL receptors and Cox2 will be blocked to assess 
whether they may contribute to NFAT-mediated neuronal death. 
This project may result in novel neuroprotective strategies in neuronal diseases like 
traumatic brain injury, spinal cord injury, Alzheimer's disease, Parkinson's disease, 
Huntington's disease, stroke or ischemia. 
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